Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Viveve Medical Inc
(NQ:
VIVE
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Jan 18, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Viveve Medical Inc
< Previous
1
2
3
4
Next >
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
January 18, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
January 18, 2023
We're starting the day with a breakdown of the biggest pre-market stock movers traders will want to watch on Wednesday morning!
Via
InvestorPlace
Nasdaq Edges Higher; Neovasc Shares Jump
January 17, 2023
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite turning higher on Tuesday.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
January 17, 2023
Via
Benzinga
Viveve Medical Seeks Strategic Alternatives After Failed Stress Urinary Incontinence Trial
January 17, 2023
Via
Benzinga
Viveve Announces Completion of Pivotal US PURSUIT Trial for Female Stress Urinary Incontinence with Final 12-month Follow-up Visits Concluded
December 15, 2022
Via
ACCESSWIRE
Viveve Announces Issuance of Second U.S. Method Patent for Treating Female Stress Urinary Incontinence
December 01, 2022
Via
ACCESSWIRE
Why Calyxt Shares Are Trading Higher By Around 116%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
January 17, 2023
Gainers Celyad Oncology SA (NASDAQ: CYAD) jumped 187% to $2.30 after gaining 21% on Friday. Celyad Oncology, last month, decided to discontinue the development of its remaining clinical program...
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
January 17, 2023
Tuesday saw 9 companies set new 52-week lows.
Via
Benzinga
Dow Tumbles 300 Points; Morgan Stanley Beats Q4 Views
January 17, 2023
U.S. stocks traded mostly lower midway through trading, with the Dow Jones dropping over 300 points on Tuesday.
Via
Benzinga
Viveve Reports Third Quarter 2022 Financial Results and Provides Corporate Update
November 10, 2022
Via
ACCESSWIRE
Viveve Announces Notice of Allowance for Second U.S. Method Patent for Treating Female Stress Urinary Incontinence
October 04, 2022
Via
ACCESSWIRE
Why Is Tritium (DCFC) Stock Up 27% Today?
January 17, 2023
Tritium (DCFC) stock is rocketing higher on Tuesday thanks to a couple of pieces of positive news from the EV charging company.
Via
InvestorPlace
XPEV Stock Alert: What to Know as Xpeng Slashes Prices
January 17, 2023
Xpeng (XPEV) stock is slipping on Tuesday after the EV maker cut the price of its cars in China to keep up with competitors.
Via
InvestorPlace
Why Is Mullen Automotive (MULN) Stock Down 11% Today?
January 17, 2023
Mullen Automotive (MULN) stock is falling on Tuesday as investors prepare for an upcoming shareholder meeting on Thursday.
Via
InvestorPlace
Why Is Viveve Medical (VIVE) Stock Down 69% Today?
January 17, 2023
Viveve Medical (VIVE) stock is falling hard on Tuesday after releasing poor results from the company's latest clinical trial.
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
January 17, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
January 17, 2023
We're starting off Tuesday with a look at the biggest pre-market stock movers that traders will want to keep an eye on today!
Via
InvestorPlace
Viveve Announces Topline Results from Pivotal U.S. PURSUIT Trial for Treating Female Stress Urinary Incontinence
January 17, 2023
Via
ACCESSWIRE
Why Applied Molecular Transport Shares Are Trading Lower By Over 55%? Here Are 47 Stocks Moving In Friday's Mid-Day Session
December 23, 2022
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
December 16, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
December 12, 2022
Monday saw 196 companies set new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
November 29, 2022
On Tuesday, 89 companies set new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
December 02, 2022
On Friday, 72 companies hit new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
November 17, 2022
OnThursday, 137 stocks made new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
November 16, 2022
On Wednesday, 70 companies set new 52-week lows.
Via
Benzinga
InvestorNewsBreaks — Viveve Medical Inc. (NASDAQ: VIVE) Releases Q3 2022 Financial Report, Corporate Update
November 11, 2022
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
Product Safety
Stocks That Hit 52-Week Lows On Friday
November 11, 2022
On Friday, 63 stocks hit new 52-week lows.
Via
Benzinga
Viveve to Report Third Quarter 2022 Financial Results and Provide Corporate Update on November 10, 2022
October 27, 2022
Via
ACCESSWIRE
Earnings Scheduled For November 10, 2022
November 10, 2022
Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report earnings for its third quarter.
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.